Florealis is a pharmaceutical startup, founded in 2013 and headquartered in Iceland, with a clear mission to improve people's health and well-being through natural medicinal products. The company's slogan, "Through science we harness the properties of nature to improve people's health and well-being," encapsulates its commitment to utilizing scientific evidence and traditional knowledge to offer high-quality herbal medicines. It has garnered attention in the investment landscape, securing a notable €673.00K through Equity Crowdfunding investment on 15 January 2020, with contributions from New Business Venture Fund and Funderbeam. Florealis is positioned at the intersection of Health Care and Pharmaceutical industries, offering natural products that are approved by European health authorities. With a strong focus on evidence-based solutions, Florealis presents itself as a promising investment opportunity in the pharmaceutical sector.
No recent news or press coverage available for Florealis.